|
|
Browse products Anticancer agents in preclinical trials Anticancer molecular libraries Other drug agents
|
MedKoo product information:
GDC-0917
Description of GDC-0917: GDC-0917 is a small-molecule peptide mimetic of SMAC/DIABLO, a key regulator of apoptosis (programmed cell death) that is designed to directly antagonize inhibitors of apoptosis proteins (IAPs). A Phase I clinical trial evaluating IAP antagonist GDC-0917 for solid tumors or lymphoma is ongoing.
Current developer: Genentech.
|
Contact MedKoo: Email: sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
||||||||||||||
About us | Services | Products | News | Careers | Contact us